DUBLIN--(BUSINESS WIRE)--The "Allergy Diagnostics Market - Growth, Trends, and Forecasts (2020-2025)" report has been added to ResearchAndMarkets.com's offering.
Allergic diseases include anaphylaxis, food allergies, forms of asthma, conjunctivitis, eczema, eosinophilic disorders, and drug and insect allergies. According to the International Study of Asthma and Allergies in Childhood (ISAAC), an estimated hay fever prevalence in 13 to 14 year old children was approximately 22.1% globally, with 29.5% in Africa, 23.9% in Asia, 15.8% in the Indian subcontinent, 23.7% in Latin America, 33.3% in North America, 12.3% in Northern and Eastern Europe, 39.8% in the Oceania, and 21.2% in the Western Europe, in 2017. It is essential for patients to receive an accurate diagnosis of hay fever. In addition, food allergies are on the rise.
An estimated 17 million Europeans have food allergies, and according to European Academy of Allergy and Clinical Immunology (EAACI), over the past decade, hospital admissions for severe allergic reactions in children have risen seven-fold. Therefore, with the growing incidences of allergic diseases, the new diagnostic market for the same is expected to grow at a good pace. Furthermore, the latest diagnostic strategies for allergies and research on new approaches for treatment are expected to drive the market.
Key Market Trends
Inhaled Allergens Segment Captures the Largest Share in the Allergy Diagnostics Market
- Allergens are of various types, such as consumed, injested, contact, inhaled, etc. Of these, the inhaled allergens hold the largest share as it is the most common among all the allergens.
- Some of the most common symptoms of allergy due to inhaled allergens are itchy eyes, sneezing, and watery eyes, etc. The rising pollution in the environment, coupled with the changing lifestyle of the people, is boosting the segment growth.
- On the other hand, food allergens still remain to exhibit the fastest growth rate owing to the unawareness among the individuals regarding certain food allergies. Hence, propelling the segment growth.
North America Captured the Largest Market Share and is Expected to Retain its Dominance
- North America is currently the largest market for allergic diagnostics globally, in terms of value, and occupies the major share of the global market. The large market size of the North American market is mainly due to the United States, which represents more than 80% of the North American market.
- There are several factors that make the United States the largest market for allergy diagnostics, such as high awareness toward allergies among the population, better regulatory guidelines which mandate allergic testing in all cases of intensive and emergency care, and better healthcare infrastructure to deal with patients' allergic situations. General allergy testing is also very high in the United States, approximately 1 in 6 Americans (around 50 million) suffer from some form of allergy and approximately 25 million Americans suffer from respiratory allergies.
Competitive Landscape
The presence of major market players, such as Biomerieux, Danaher Corporation, Omega Diagnostics, Siemens Healthineers, Thermo Fischer Scientific among others is intensifying the market competition.
The increasing innovation and rise in investment for various public and private organizations are expected to intensify the industry rivalry across the world. In 2019, AllerGenis introduced 'Luminex xMap Technology' for diagnosis of food allergies in the patients.
Key Topics Covered:
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidences of Allergic Diseases
4.2.2 Environmental Pollution
4.3 Market Restraints
4.3.1 Lack of Awareness About Allergic Diseases
4.3.2 Affordability of Allergy Diagnostics
4.4 Porter's Five Forces Analysis
5 MARKET SEGMENTATION
5.1 By Allergen
5.1.1 Inhaled Allergens
5.1.2 Food Allergens
5.1.3 Other Allergens
5.2 By Product
5.2.1 Instruments
5.2.2 Consumables
5.2.3 Luminometers
5.3 By End User
5.3.1 Diagnostic Laboratories
5.3.2 Hospitals
5.3.3 Other End Users
5.4 By Geography
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 bioMerieux
6.1.2 Danaher Corporation
6.1.3 Hitachi Chemical Diagnostics Inc.
6.1.4 HOB Biotech Group Corp. Ltd
6.1.5 HYCOR Biomedical
6.1.6 Lincoln Diagnostics Inc.
6.1.7 Omega Diagnostics
6.1.8 Siemens Healthineers AG
6.1.9 Stallergenes Greer Ltd
6.1.10 Thermo Fischer Scientific
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/8o4osq
